Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|November 6, 1996

Imation begins shipping 8 x 10 DryView

Imation last week began commercial shipments of DryView 8300,the 8 x 10 version of its DryView dry-process laser printing technology.DryView 8300 is targeted at nuclear medicine, ultrasound, andsmall-format applications. Imation last month marked the

Imation last week began commercial shipments of DryView 8300,the 8 x 10 version of its DryView dry-process laser printing technology.DryView 8300 is targeted at nuclear medicine, ultrasound, andsmall-format applications.

Imation last month marked the 1000th installation of its 14x 17 DryView printer, DryView 8700. Imation donated the 1000thDryView 8700 to the Mayo Clinic Foundation in Rochester, MN. Asof October, Imation had sold 1500 DryView printers.

In other DryView news, Imation is planning to release an 11x 14 version of DryView. The new printer, to be called DryView8500, will be targeted at computed radiography applications, aswell as international markets, according to the company.

Imation last week released financial results for its thirdquarter (end-September) that indicated strong profit growth. Imationposted a profit of $11.8 million on revenues of $559.3 million.Revenues were up 2.4% compared with the same period last yearfor the 3M businesses that were later spun off to create Imation.The revenue growth was the first in 11 quarters for the businessunits, according to Imation chairman and CEO William Monahan.


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.